BioCentury
ARTICLE | Company News

Oxford Molecular, Yamanouchi deal

August 9, 1999 7:00 AM UTC

OMG subsidiary Cambridge Combinatorial Ltd. (Cambridge, U.K.) will design and synthesize compounds against two of Yamanouchi's targets in return for research fees, milestone payments and royalties. Th...